ADTX ADITXT INC Company Mergers 8-K Filing 2025 - Acquisition Agreement On April 1, 2024, Aditxt, Inc. entered into an agreement for Adivir, its subsidiary, to acquire Appili Therapeutics, with multiple amendments extending deadlines for completion and financial disclosures through early 2025, including a $250,000 fee paid to Appili on various dates.Get access to all SEC 8-K filings of the ADITXT INC